NO791339L - Fremgangsmaate for stabilisering av en tiazolforbindelse - Google Patents

Fremgangsmaate for stabilisering av en tiazolforbindelse

Info

Publication number
NO791339L
NO791339L NO791339A NO791339A NO791339L NO 791339 L NO791339 L NO 791339L NO 791339 A NO791339 A NO 791339A NO 791339 A NO791339 A NO 791339A NO 791339 L NO791339 L NO 791339L
Authority
NO
Norway
Prior art keywords
stabilization
procedure
thiazole compound
thiazole
compound
Prior art date
Application number
NO791339A
Other languages
English (en)
Other versions
NO150317B (no
NO150317C (no
Inventor
Horst Felsch
Gerhard Hantich
Original Assignee
Pharmaceutical Licences Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaceutical Licences Co filed Critical Pharmaceutical Licences Co
Publication of NO791339L publication Critical patent/NO791339L/no
Publication of NO150317B publication Critical patent/NO150317B/no
Publication of NO150317C publication Critical patent/NO150317C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO791339A 1978-04-25 1979-04-23 Fremgangsmaate for stabilisering av 4-metyl-5-(2`-klor-etyl)-tiazol NO150317C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT296178A AT358530B (de) 1978-04-25 1978-04-25 Stabilisierungsverfahren

Publications (3)

Publication Number Publication Date
NO791339L true NO791339L (no) 1979-10-26
NO150317B NO150317B (no) 1984-06-18
NO150317C NO150317C (no) 1984-09-26

Family

ID=3543124

Family Applications (1)

Application Number Title Priority Date Filing Date
NO791339A NO150317C (no) 1978-04-25 1979-04-23 Fremgangsmaate for stabilisering av 4-metyl-5-(2`-klor-etyl)-tiazol

Country Status (23)

Country Link
US (1) US4247702A (no)
EP (1) EP0005121B1 (no)
JP (1) JPS54147914A (no)
AT (1) AT358530B (no)
AU (1) AU523518B2 (no)
CA (1) CA1113941A (no)
CS (1) CS208779B2 (no)
DD (1) DD142962A5 (no)
DE (2) DE2963835D1 (no)
DK (1) DK155978C (no)
ES (1) ES480590A1 (no)
FI (1) FI66120C (no)
GR (1) GR66987B (no)
HU (1) HU179741B (no)
IE (1) IE48778B1 (no)
IL (1) IL57292A (no)
NO (1) NO150317C (no)
NZ (1) NZ190240A (no)
PT (1) PT69532A (no)
SU (1) SU959626A3 (no)
UA (1) UA5545A1 (no)
YU (1) YU42302B (no)
ZA (1) ZA791661B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58159425A (ja) * 1982-03-18 1983-09-21 Fujisawa Pharmaceut Co Ltd ゲル基剤
SE9303281D0 (sv) * 1993-10-07 1993-10-07 Astra Ab New formulation
EP1220849B1 (en) * 1999-10-15 2004-05-19 Sucampo AG Bicyclic compounds composition and method for stabilizing the same
US9884024B2 (en) * 2005-12-27 2018-02-06 Hemant N Joshi Physically dispersed, molecularly dissolved and/or chemically bound drug(s) in an empty, hard capsule shell composition
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2844512A (en) * 1954-11-05 1958-07-22 Upjohn Co Fumagillin enveloped in fatty or waxy substance and enclosed in ultraviolet opaque container
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
FR1536904A (fr) * 1962-12-19 1968-09-02 Smith Kline French Lab Procédé de préparation de pilules pharmaceutiques à libération progressive de leur principe actif
SE319577B (no) * 1966-03-08 1970-01-19 Astra Ab
JPS4971127A (no) * 1972-11-18 1974-07-10
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.
NL7510104A (nl) * 1975-08-27 1977-03-01 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
DE2631281A1 (de) * 1976-07-12 1978-01-19 Kali Chemie Pharma Gmbh Verfahren zur erhoehung der loeslichkeit von schwerloeslichen arzneistoffen zum zwecke deren applikation in gelatinekapseln
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof

Also Published As

Publication number Publication date
NZ190240A (en) 1980-10-24
DE2916573A1 (de) 1979-10-31
AU4637379A (en) 1979-11-01
ES480590A1 (es) 1980-08-16
IE790836L (en) 1979-10-25
FI66120B (fi) 1984-05-31
IE48778B1 (en) 1985-05-15
DK167879A (da) 1979-10-26
PT69532A (de) 1979-05-01
NO150317B (no) 1984-06-18
IL57292A (en) 1982-11-30
US4247702A (en) 1981-01-27
AU523518B2 (en) 1982-07-29
EP0005121A2 (de) 1979-10-31
ATA296178A (de) 1980-02-15
EP0005121B1 (de) 1982-10-13
HU179741B (en) 1982-12-28
DK155978C (da) 1989-10-30
SU959626A3 (ru) 1982-09-15
CS208779B2 (en) 1981-09-15
NO150317C (no) 1984-09-26
CA1113941A (en) 1981-12-08
JPS6337791B2 (no) 1988-07-27
FI791324A (fi) 1979-10-26
AT358530B (de) 1980-09-10
DE2963835D1 (en) 1982-11-18
DE2916573C2 (de) 1982-09-02
UA5545A1 (uk) 1994-12-28
DD142962A5 (de) 1980-07-23
YU42302B (en) 1988-08-31
YU91079A (en) 1984-10-31
JPS54147914A (en) 1979-11-19
ZA791661B (en) 1980-04-30
EP0005121A3 (en) 1979-11-28
GR66987B (no) 1981-05-15
DK155978B (da) 1989-06-12
FI66120C (fi) 1984-09-10

Similar Documents

Publication Publication Date Title
NO148281C (no) Fremgangsmaate ved fremstilling av allergenholdige forbindelser
FI792824A (fi) Foerfarande foer framstaellning av oxidering inhiberande aemnen
IT7946846A0 (it) Procedimento per la produzione dimateriali composti
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO150155C (no) Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser
DK533979A (da) Fremgangsmaade til fremstilling af thiazolylderivater
JPS5540700A (en) Manufacture of heterocyclic compound
JPS56138134A (en) Manufacture of organic compound
NO791139L (no) Fremgangsmaate for fremstilling av lysergolderivater
FI791562A (fi) Foerfarande foer framstaellning av 4-amino-2-piperidinokinazolinderivat
SE433081B (sv) Forfarande for framstellning av cefalosporinforeningar
SE426069B (sv) Forfarande for framstellning av ett kristallint cefalosporinderivat
SE7902238L (sv) Forfarande for bestemning av alfa-amylas
JPS54109959A (en) Manufacture of organic compound
NO791339L (no) Fremgangsmaate for stabilisering av en tiazolforbindelse
SE438337B (sv) Forfarande for framstellning av 2-(metyl)-7-substituerade 3-cefem-4-karboxylsyraforeningar
FI793221A (fi) Foerfarande foer framstaellning av substituerade pyrroldiestrar
JPS54117473A (en) Manufacture of thiazole derivative and novel thiazole compound
NO791599L (no) Fremgangsmaate for fremstilling av dibenzyletere
NO793989L (no) Fremgangsmaate til fremstilling av et krystallinsk salt av et cefalosporinderivat
NO150995C (no) Fremgangsmaate til fremstilling av en sekk forsynt med kryssbunn
NO791894L (no) Framgangsmaate for framstilling av kornorientert elektrostaal
NO791199L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme forbindelser
FI792983A (fi) Stoedkonstruktion foer tillfaellig positionering av ett uppraettstaoende element